Tempest Therapeutics TPST
NASDAQ TPST
$0.52 0.00 (-0.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Share-based Compensation (2012 - 2026)

Updated

Tempest Therapeutics' Share-based Compensation came in at $347,000 for Q3 2018, down 24.4% from $459,000 a year earlier and down 34.5% from the prior quarter.

Analysis

Tempest Therapeutics (TPST) Share-based Compensation (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2018, Tempest Therapeutics reported Share-based Compensation of $1.78 million, down 75.9% year-over-year; for FY2017, it was $6.89 million, down 25.2% from FY2016.

  • Share-based Compensation carries a five-year compound annual growth rate of 37.9% (FY2012 to FY2017).
  • Going back by year, Share-based Compensation was $9.22 million in FY2016 (-52.3%), $19.34 million in FY2015 (+55.9%), $12.41 million in FY2014 (+143.6%) and $5.09 million in FY2013 (+268.6%).
  • The Q3 2018 figure represents the lowest quarterly Share-based Compensation since Q3 2012.
  • Year-over-year, Share-based Compensation has declined for five consecutive quarters, with an average decline of 43.2% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q1 2015 (growth of 634.4%), and the weakest in Q2 2018 (a decline of 88.4%).
  • Business Quant data shows TPST's Share-based Compensation at $530,000 (Q2 2018), $382,000 (Q1 2018) and $516,000 (Q4 2017) in the three quarters before Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 166.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 249.00 Mn
10 Tempest Therapeutics 7.98 Mn -22.34 Mn - -119,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -119,000.00
Dec 31, 2025 576,000.00
Sep 30, 2025 61,000.00
Jun 30, 2025 1.09 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 1.33 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.10 Mn
Sep 30, 2023 563,000.00
Jun 30, 2023 440,000.00
Mar 31, 2023 446,000.00
Dec 31, 2022 428,000.00
Sep 30, 2022 438,000.00
Jun 30, 2022 367,000.00
Mar 31, 2022 328,000.00
Dec 31, 2021 278,000.00
Sep 30, 2021 296,000.00
Jun 30, 2021 411,000.00
API Access

Tempest Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TPST&period=max&api_key=YOUR_API_KEY